Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test
There is increasing attention on the clinical utility and value of pharmacogenetic (PGx) testing to individualize medication management. Most clinical practice guidelines from medical professional societies do not recommend routine PGx testing, with a few key exceptions.
James M. Stevenson+4 more
wiley +1 more source
Exogenous melatonin administration modifies cutaneous vasoconstrictor response to whole body skin cooling in humans [PDF]
Ken Aoki+6 more
openalex +1 more source
Multiple Mesenchymal Stem Cell Derived Extracellular Vesicle Administration Accelerates Healing and Ameliorates Tissue Scarring Compared with Single Application in Full Thickness Cutaneous Wounds [PDF]
Hasti Tashak Golroudbari+10 more
openalex +1 more source
Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs [PDF]
Rebecca M. Stanclift, Stephen D. Gilson
openalex +1 more source
Pharmacokinetics of Two Formulations of Altrenogest Administered to Mares
Pharmacokinetics of altrenogest in mares to determine expected concentrations of plasma altrenogest associated with oral and intramuscular administration. Quantification of altrenogest in mares is of increasing importance with prohibited formulations and restrictions on administration.
Jaymie Loy+5 more
wiley +1 more source
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo+22 more
wiley +1 more source
Cutaneous blood flow during intradermal NO administration in young and older adults: roles for calcium-activated potassium channels and cyclooxygenase? [PDF]
Naoto Fujii+6 more
openalex +1 more source
Cutaneous lymphocytic vasculitis after administration of
Camilla Vassallo+6 more
openalex +1 more source
Abstract Objective Investigate real‐world outcomes in drug‐resistant epilepsy (DRE) patients treated with cenobamate as adjunctive treatment to other antiseizure medications (ASMs) within the Early Access Programs (EAP) in Germany, France, and the United Kingdom.
Sylvain Rheims+13 more
wiley +1 more source